Document Detail

Infliximab treatment in refractory Kawasaki syndrome.
MedLine Citation:
PMID:  18537019     Owner:  NLM     Status:  MEDLINE    
Kawasaki syndrome is one of the commonest vasculitides in pediatric age group with devastating consequences if not treated early. Intravenous Gammaglobulin leads to rapid amelioration of clinical symptoms and significantly decreases the risk of development of coronary artery aneurysms. Occasionally, Kawasaki disease may be resistant to I/V IgG. We present our experience with one such patient who ultimately respondend to infliximab therapy.
Meenakshi Girish; Girish Subramaniam
Related Documents :
16581699 - Mid-term outcome after carotid artery stenting depends on presence of coronary artery d...
8956549 - A case of relapsing kawasaki disease and review of the literature.
7595119 - Ventricular gradient variability. new ecg method for detection of ischemic heart disease.
16749889 - Coronary arteries: imaging, reconstruction, and fluid dynamic analysis.
11838929 - A case-control study of plasma homocysteine levels in south indians with and without co...
10212169 - Effects of l- and d-arginine on the basal tone of human diseased coronary arteries and ...
9282669 - Comparison of mr angiography with contrast angiography for the diagnosis of carotid art...
6379369 - The ring technique for end-to-side microvascular anastomosis.
23509329 - A case of tracheal varices in an adolescent patient with cyanotic heart disease.
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2008-06-08
Journal Detail:
Title:  Indian journal of pediatrics     Volume:  75     ISSN:  0973-7693     ISO Abbreviation:  Indian J Pediatr     Publication Date:  2008 May 
Date Detail:
Created Date:  2008-06-09     Completed Date:  2008-08-13     Revised Date:  2010-01-14    
Medline Journal Info:
Nlm Unique ID:  0417442     Medline TA:  Indian J Pediatr     Country:  India    
Other Details:
Languages:  eng     Pagination:  521-2     Citation Subset:  IM    
Children's Hospital, Midas Heights, Nagpur, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Inflammatory Agents / therapeutic use*
Antibodies, Monoclonal / therapeutic use*
Child, Preschool
Mucocutaneous Lymph Node Syndrome / drug therapy*
Treatment Outcome
Reg. No./Substance:
0/Anti-Inflammatory Agents; 0/Antibodies, Monoclonal; 0/infliximab
Comment In:
Indian J Pediatr. 2009 Nov;76(11):1184; author reply 1184   [PMID:  20072867 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Semilobar holoprosencephaly in Seckel syndrome.
Next Document:  Round pneumonia in children.